IO Biotech, Inc.
IO Biotech, Inc. (IOBT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IOBT · as of Jun 9, 2026
Key Statistics
Explore IO Biotech, Inc. Data
iobt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
The IOBT analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $0.50, representing +3961.74% upside from the current price of $0.01.
Competitors & Peers
iobt competitorsIOBT
ACET
CUE
HOWL
INKT
KPTIStock Performance
Full HistoryAbout IO Biotech, Inc.
IO Biotech, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating immune-modulating cancer treatments. These therapies leverage its proprietary T-win technology platform. The company's…
what is io biotech, inc. · iobt stock overview · io biotech, inc. company profile · who is io biotech, inc. ceo · iobt NASDAQ · io biotech, inc. headquarters · io biotech, inc. business segments
About Stock Overview & Key Data
IO Biotech, Inc. (IOBT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 5, 2021. As of the latest trading session, IOBT stock price is $0.01, with a market capitalization of $885,690. The stock has returned -98.77% over the past 12 months and -97.98% year-to-date.
According to 6 Wall Street analysts, the consensus rating for IO Biotech, Inc. stock is Buy, with an average 12-month price target of $0.50. In fiscal year 2024, IO Biotech, Inc. reported revenue of — and net income of -$95.5M. For detailed data — including IO Biotech, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IO Biotech, Inc. (IOBT) stock price is $0.01. The stock is traded on NASDAQ under the ticker symbol IOBT. The 52-week range is $0.01 – $2.79.